MCTRAX‑MF Tablets | Tranexamic Acid 500 mg + Mefenamic Acid 250 mg

TELSWIT‑H
Telswit‑H Tablets | Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg
July 28, 2025
Racole‑SB 130
Racole‑SB 130 Capsules | Itraconazole 130 mg
July 28, 2025
MCTRAX‑MF

MCTRAX‑MF Tablets deliver a dual-action menstrual relief formula combining Tranexamic Acid 500 mg (antifibrinolytic) and Mefenamic Acid 250 mg (NSAID). This combination reduces excessive menstrual blood loss and relieves cramps associated with dysmenorrhea.

🔹 Benefits:

  • Tranexamic Acid stabilizes clot formation and reduces menstrual blood volume

  • Mefenamic Acid inhibits prostaglandin synthesis, easing uterine cramps and inflammation

  • Dual action offers both hemostatic control and analgesia

🔹 Indications:

  • Heavy menstrual bleeding (menorrhagia)

  • Painful menstruation (dysmenorrhea)

  • Uterine bleeding due to hormonal imbalance

🔹 Dosage:

Take one tablet three times a day for up to 5 days during menstruation, or as advised. Begin at onset of bleeding.

🔹 Precautions:

  • Avoid in patients with thrombosis or clotting disorders

  • Use with caution in those with renal impairment or peptic ulcers

  • May cause nausea or GI upset—take with food

  • Not recommended during pregnancy or breastfeeding

🔹 Storage:

Keep in a cool, dry place below 25 °C, away from sunlight and moisture.

MCTRAX‑MF offers powerful, rapid relief from heavy menstrual bleeding and discomfort through a scientifically balanced dual-action tablet.

📄 PRODUCT LIST
×